PLASMA LEVELS OF HEPARANASE AS A MARKER OF TUMOR PROGRESSION AND AGGRESSIVENESS IN PATIENTS WITH COLORECTAL AND BREAST CANCER

被引：0
|
作者：
Kuten, J. [1 ]
Haim, N. [2 ]
Epelbaum, R. [1 ]
Fried, G. [1 ]
Ben Itzhak, O. [3 ]
Danus, S. [1 ]
Shaft, I. [3 ]
Vlodavsky, I. [3 ]
机构：
[1] Rambam Med Ctr, Haifa, Israel
[2] Rambam Hlth Care Campus, Oncol, Haifa, Israel
[3] Technion Israel Inst Technol, Rappaport Fac Med, Haifa, Israel
来源：
ANNALS OF ONCOLOGY | 2010年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
下载
收藏
页码：76 / 76
页数：1
相关论文
共 50 条
  • [1] Plasma Levels of Heparanase as Marker of Tumour Aggressiveness and Stage of Disease in Patients With Colorectal Cancer
    Dudnik, E.
    Kuten, A.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S398 - S398
  • [2] Cytokeratin 20 as a marker of tumor progression or dissemination in patients with colorectal cancer
    Garrido S, Marcelo
    Ramirez, Pablo, V
    Risueno A, Concepcion
    Orellana U, Eric
    Galindo A, Hector
    Alvarez Z, Manuel
    REVISTA MEDICA DE CHILE, 2008, 136 (04) : 482 - 490
  • [3] Heregulin as a marker for breast cancer tumor progression.
    Lupu, R
    MEDICINA-BUENOS AIRES, 1996, 56 (05) : 630 - 631
  • [4] Variations in tumor marker levels in metastatic breast cancer patients according to tumor subtypes
    Kos, T.
    Aksoy, S.
    Sendur, M. A. N.
    Arik, Z.
    Civelek, B.
    Kandemir, N.
    Ozdemir, N. Y.
    Zengin, N.
    Altundag, K.
    JOURNAL OF BUON, 2013, 18 (03): : 608 - 613
  • [5] Plasma Levels of Decorin Increased in Patients during the Progression of Breast Cancer
    Hosoya, Tokuko
    Oda, Goshi
    Nakagawa, Tsuyoshi
    Onishi, Iichiroh
    Hosoya, Tadashi
    Ishiguro, Megumi
    Ishikawa, Toshiaki
    Uetake, Hiroyuki
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (23)
  • [6] PREOPERATIVE TUMOR-MARKER LEVELS IN PATIENTS WITH BREAST-CANCER AND THEIR PROGNOSIS
    VANDALEN, A
    TUMOR BIOLOGY, 1990, 11 (04) : 189 - 195
  • [7] Circulating basophil count as a prognostic marker of tumor aggressiveness and survival outcomes in colorectal cancer
    Liu, Qi
    Luo, Dakui
    Cai, Sanjun
    Li, Qingguo
    Li, Xinxiang
    CLINICAL AND TRANSLATIONAL MEDICINE, 2020, 9 (01):
  • [8] Elevated plasma fibrinogen levels as an independent prognostic marker in breast cancer patients
    Krenn-Pilko, S.
    Langsenlehner, U.
    Thurner, E. -M
    Stojakovic, T.
    Pichler, M.
    Gerger, A.
    Kapp, K. S.
    Langsenlehner, T.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2014, 190 : 26 - 26
  • [9] Plasma CXCL3 Levels Are Associated with Tumor Progression and an Unfavorable Colorectal Cancer Prognosis
    Cui, Can
    Zhang, Rui
    Gu, Feng
    Pei, Yunfeng
    Sun, Li
    Huang, Yueyang
    Niu, Guoping
    Li, Jian
    JOURNAL OF IMMUNOLOGY RESEARCH, 2022, 2022
  • [10] PKCα expression is a marker for breast cancer aggressiveness
    Lonne, Gry Kalstad
    Cornmark, Louise
    Zahirovic, Iris Omanovic
    Landberg, Goran
    Jirstrom, Karin
    Larsson, Christer
    MOLECULAR CANCER, 2010, 9
12345